{"id":"W2979643211","doi":"10.1182/blood.v118.21.480.480","title":"Vantage 095: Vorinostat in Combination with Bortezomib in Salvage Multiple Myeloma Patients: Final Study Results of a Global Phase 2b Trial","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bortezomib; Multiple myeloma; Regimen; Vorinostat; Clinical endpoint; Internal medicine; Phases of clinical research; Dexamethasone; Oncology; Salvage therapy; Refractory (planetary science); Gastroenterology; Progressive disease; Clinical trial; Combination therapy; Pharmacology; Chemotherapy; Histone deacetylase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003114628,0.0001981053,0.0004365274,0.0001855834,0.00002902381,0.000008618829,0.0001155714,0.00006903172,0.00002010973],"category_scores_gemma":[0.0004776355,0.0001546389,0.00005326604,0.0004718034,0.00005958033,0.0001357117,0.00005543583,0.0001697457,0.000007645923],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001058537,"about_ca_system_score_gemma":0.0001497998,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002406655,"about_ca_topic_score_gemma":0.00363874,"domain_scores_codex":[0.9979316,0.0001751433,0.0005772517,0.0003837933,0.0005570137,0.0003751772],"domain_scores_gemma":[0.9990966,0.00009435432,0.0001638121,0.0003516699,0.000137391,0.0001561267],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1567688,0.0690781,0.7672181,0.00003086725,0.0001284133,0.0009538707,0.001043931,2.344739e-7,0.00004485064,0.00001115602,0.00001132094,0.004710367],"study_design_scores_gemma":[0.4270502,0.01565042,0.5560226,0.00006559171,0.00006508053,0.000003981868,0.00026336,0.00004942578,0.0007396867,0.000009183074,0.00000597984,0.00007454725],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952698,0.00002190862,0.000005585508,0.00001783459,0.00005609995,0.003321963,0.0002514021,0.00002376178,0.001031657],"genre_scores_gemma":[0.9990432,0.000006370274,0.0005323701,0.0000095642,0.0000236499,0.0001388156,0.00019639,0.00001570353,0.00003395354],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2702814,"threshold_uncertainty_score":0.6305991,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04700091844040593,"score_gpt":0.3249367596965943,"score_spread":0.2779358412561884,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}